Maynard Um
-
-
-
-
-
-
-
IDEAYA Biosciences partners with Roche for pancreatic cancer study
-
-
-
-
-
-
-
Ideaya Biosciences (IDYA) PT Raised to $53 at RBC Capital
-
-
-
-
-
-
-
RBC Capital on Ideaya Biosciences (IDYA): 'We remain positive on the upcoming data readout'
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Ideaya Biosciences (IDYA)
-
-
-
-
-
-
-
GSK terminates collaboration agreement with IDEAYA Biosciences
-
-
-
-
-
-
-
Why UBS says Q4 is eventful for SMID oncology stocks
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Ideaya Biosciences (IDYA)
-
444,171 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

